Costs and Benefits of Alternative Strategies to Control the Spread of Livestock-Acquired Methicillin-Resistant Staphylococcus Aureus From Pig Production

Jan 1, 2020, 00:00
10.1016/j.jval.2019.07.006
https://www.valueinhealthjournal.com/article/S1098-3015(19)32302-2/fulltext
Title : Costs and Benefits of Alternative Strategies to Control the Spread of Livestock-Acquired Methicillin-Resistant Staphylococcus Aureus From Pig Production
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32302-2&doi=10.1016/j.jval.2019.07.006
First page : 89
Section Title : HEALTH POLICY ANALYSIS
Open access? : No
Section Order : 89

Background

Livestock-acquired methicillin-resistant Staphylococcus aureus (LA-MRSA) is a concern in healthcare and a political priority in some countries.

Objective

This study investigates the net societal costs of 2 alternative strategies for controlling LA-MRSA in Denmark: (1) eradicating LA-MRSA in all pig housing units, and (2) containing LA-MRSA within the units.

Methods

Benefits and costs are considered for affected economic sectors: healthcare, pig production, pig-related industries, and public administration.

Results

The cost to society of eradication is estimated at €2.3 to €2.5 billion (present value). Containment will cost €55 to €93 million. For both strategies, the main cost lies in primary pig production—for containment this is mainly due to establishing and operating anterooms and shower rooms, and for eradication it is due to production losses, loss of genetic resources, and costs of cleaning and disinfection.

Conclusion

Compared with these costs, health economic benefits are moderate for both strategies. Containment is superior to eradication when measured by a benefit-cost ratio.

Categories :
  • Epidemiology & Public Health
  • Geographic & Regional
  • Health Policy & Regulatory
  • Industry
  • Organizational Practices
  • Public Health
  • Public Spending & National Health Expenditures
  • Safety & Pharmacoepidemiology
Tags :
  • containment
  • costs
  • eradication
  • MRSA CC398
Regions :
ViH Article Tags :